摘要
目的 分析在治疗扩张型心肌病中应用左西孟旦结合辅酶Q10治疗的医学价值。方法 将2023年1月-2023年12月内就诊的60例扩张型心肌病的患者作为研究对象，均接受基础治疗，对照组30例增加辅酶Q10治疗，观察组30例增加左西孟旦，对比两组患者治疗前后的心功能、血压指标。结果 护理前，两组患者对比差异不具有统计学意义，（P﹥0.05）。护理后，观察组HR低于对照组，LVD优于对照组，血压优于对照组，差异对比有统计学意义（P﹤0.05）。结论 在治疗扩张型心肌病中应用左西孟旦结合辅酶Q10治疗可提高心功能，降低血压，让患者受益。
关键词： 左西孟旦；辅酶Q10治疗；扩张型心肌病；心功能；心肌细胞；心肌收缩
Abstract
Objective To analyze the medical value of using levosimendan combined with coenzyme Q10 in the treatment of dilated cardiomyopathy. Methods Sixty patients with dilated cardiomyopathy who received treatment between January 2023 and December 2023 were selected as the study subjects. All patients received basic treatment, with 30 in the control group receiving additional treatment with coenzyme Q10 and 30 in the observation group receiving additional treatment with levosimendan. The cardiac function and blood pressure indicators of the two groups of patients before and after treatment were compared. Results Before treatment, there was no statistically significant difference between the two groups of patients (P>0.05). After nursing, the HR of the observation group was lower than that of the control group, LVD was better than that of the control group, and blood pressure was better than that of the control group, with statistically significant differences (P<0.05). Conclusion The use of levosimendan combined with coenzyme Q10 in the treatment of dilated cardiomyopathy can improve cardiac function, lower blood pressure, and benefit patients.
Key words： Levosimendan; Coenzyme Q10 therapy; Dilated cardiomyopathy; Heart function; Myocardial cells; Myocardial contraction
参考文献 References
[1] 陈恺蓓,杨婧,刘玲玉,等.三维斑点追踪超声心动图技术对扩张型心肌病患儿左心室舒张功能的评估及左心室射血分数恢复的预测[J/OL].心脏杂志,2026,(05):546-553[2025-12-15].
[2] 何清,樊佳溶,熊昊哲,等.“新四联”疗法联合中医益气温阳法治疗扩张型心肌病1例并文献复习[J].广西医学,2025,47(11):1693-1697.
[3] 孔慧雅,郭现辉,张会超,等.中药治疗扩张型心肌病的临床证据与方法学质量分析[J].中西医结合心脑血管病杂志,2025,23(22):3372-3379.
[4] 王叶宝,林永萍,刘玲,等.血清miR-210、TSG-6、CTRP3水平与扩张型心肌病患者心肌纤维化及预后的关系[J].实用医学杂志,2025,41(23):3690-3696.
[5] 梅丽军,姚筱,王西强,等.左西孟旦联合辅酶Q10治疗扩张型心肌病临床疗效研究[J].陕西医学杂志,2023,52(10): 1404-1406.
[6] 詹继东,艾丹,肖婷,等.重症心力衰竭患者的左西孟旦结合重组人脑利钠肽治疗效果及对心功能、炎性因子的影响[J].心血管病防治知识,2023,13(30):17-19+23.
[7] 边睿雪.左西孟旦联合重组人脑利钠肽治疗急性心力衰竭的疗效及对心功能的影响[J].临床合理用药,2025, 18(34):50-52.
[8] 程昕.左西孟旦联合培哚普利叔丁胺治疗心肌梗死伴充血性心力衰竭的临床效果[J].临床合理用药,2025,18(31): 59-62.
[9] 郝家亮,梁晓凤,李婷.单次和重复注射左西孟旦治疗射血分数降低型心力衰竭患者的效果[J].临床医学研究与实践,2025,10(30):72-76.
[10] 金玲玲,张秋芳. 冻干重组人脑利钠肽与左西孟旦联合治疗对急性重症心力衰竭患者心脏功能的影响[J]. 现代医学与健康研究（电子版）,2023,7(20):60-62.